Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

SHBG may be a useful early indicator and treatment target for PCOS.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

DHT, a testosterone byproduct, causes male pattern baldness.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

A systematic approach is crucial for managing hair loss in women.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.